α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Por um escritor misterioso

Last updated 17 junho 2024

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Labetalol is one of the most used drugs for the treatment of hypertension. This molecule is able to bind to both alpha-1 (α1) and beta (β) adrenergic …

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes

Arrhythmogenic Remodeling of β2 Versus β1 Adrenergic Signaling in the Human Failing Heart

Dopaminergic and adrenergic receptors synergistically stimulate browning in 3T3-L1 white adipocytes

Labetalol - an overview

α1-Adrenergic receptors - ScienceDirect

In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane - ScienceDirect

PDF) In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane

What Is the Role of β-Adrenergic Signaling in Heart Failure?

Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia - ScienceDirect

Modulation of β-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action - ScienceDirect

Frontiers Astrocytes, Noradrenaline, α1-Adrenoreceptors, and Neuromodulation: Evidence and Unanswered Questions

Erythrocytes as model cells for biocompatibility assessment, cytotoxicity screening of xenobiotics and drug delivery - ScienceDirect

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes

Atherosclerosis: lessons from LXR and the intestine: Trends in Endocrinology & Metabolism

Drugs and Toxins - ScienceDirect

Recomendado para você